Meister B, Gömüç B, Suarez E, Ishii Y, Dürr K, Gillberg L. Hypothalamic proopiomelanocortin (POMC) neurons have a cholinergic phenotype. The European journal of neuroscience 24 (10) , 2731-40 (2006) PubMed ID:(17156199)

Boggiano M, Chandler P, Oswald K, Rodgers R, Blundell J, Ishii Y, Beattie A, Holch P, Allison D, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost H, Klaus S, Thöne-Reineke C, Benoit S, Seeley R, Beck-Sickinger A, Koglin N, Raun K, Madsen K, Wulff B, Stidsen C, Birringer M, Kreuzer O, Deng X, Whitcomb D, Halem H, Taylor J, Dong J, Datta R, Culler M, Ortmann S, Castañeda T, Tschöp M. PYY3-36 as an anti-obesity drug target. Obesity reviews : an official journal of the International Association for the Study of Obesity 6 (4) , 307-22 (2005) PubMed ID:(16246216 )

Ishii Y, Blundell J, Halford J, Upton N, Porter R, Johns A, Jeffrey P, Summerfield S, Rodgers R. Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behavioural brain research 157 (2) , 331-41 (2005) PubMed ID:(15639184)

Ishii Y, Blundell J, Halford J, Upton N, Porter R, Johns A, Rodgers R. Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S. Behavioural brain research 160 (1) , 11-24 (2005) (Epub 18 Dec 2004) PubMed ID:(15836896)

Ishii Y, Blundell J, Halford J, Upton N, Porter R, Johns A, Rodgers R. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiology & behavior 81 (1) , 129-40 (2004) PubMed ID:(15059692 )